Rep. Robert Bresnahan, Jr. Sells Off Shares of Celsius Holdings, Inc. (NASDAQ:CELH)

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Celsius Holdings, Inc. (NASDAQ:CELH). In a filing disclosed on February 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Celsius stock on January 13th. The trade occurred in the Representative’s “JOINT OWNERSHIP LPL ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of Lowe’s Companies (NYSE:LOW) on 2/7/2025.
• Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 2/3/2025.
• Purchased $1,001 – $15,000 in shares of Take-Two Interactive Software (NASDAQ:TTWO) on 2/3/2025.
• Purchased $1,001 – $15,000 in shares of Intel (NASDAQ:INTC) on 2/3/2025.
• Purchased $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 1/30/2025.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 1/30/2025.
• Sold $1,001 – $15,000 in shares of Robinhood Markets (NASDAQ:HOOD) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of NVIDIA (NASDAQ:NVDA) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of Manhattan Associates (NASDAQ:MANH) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 1/29/2025.

Celsius Trading Down 1.4 %

Shares of CELH stock opened at $22.34 on Friday. The company’s fifty day moving average price is $26.52 and its 200-day moving average price is $30.91. The stock has a market cap of $5.25 billion, a PE ratio of 31.03, a price-to-earnings-growth ratio of 2.44 and a beta of 1.78. Celsius Holdings, Inc. has a 12 month low of $21.10 and a 12 month high of $99.62.

Institutional Trading of Celsius

Hedge funds and other institutional investors have recently bought and sold shares of the business. Talon Private Wealth LLC purchased a new stake in Celsius in the 4th quarter valued at $1,065,000. Northern Trust Corp raised its position in Celsius by 15.7% during the 4th quarter. Northern Trust Corp now owns 1,347,662 shares of the company’s stock worth $35,497,000 after buying an additional 183,163 shares during the last quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of Celsius by 1.1% in the fourth quarter. The Manufacturers Life Insurance Company now owns 130,894 shares of the company’s stock valued at $3,448,000 after acquiring an additional 1,467 shares in the last quarter. Nebula Research & Development LLC purchased a new stake in Celsius in the 4th quarter valued at approximately $613,000. Finally, T. Rowe Price Investment Management Inc. acquired a new position in Celsius during the fourth quarter worth $8,702,000. 60.95% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CELH has been the subject of several recent research reports. Needham & Company LLC reiterated a “buy” rating and set a $38.00 target price on shares of Celsius in a report on Tuesday, January 28th. Morgan Stanley reiterated an “equal weight” rating and set a $42.00 price objective on shares of Celsius in a research report on Thursday, December 26th. UBS Group reduced their price objective on Celsius from $45.00 to $39.00 and set a “buy” rating for the company in a research note on Thursday, January 16th. Jefferies Financial Group dropped their price target on shares of Celsius from $44.00 to $40.00 and set a “buy” rating for the company in a research report on Thursday, December 19th. Finally, Deutsche Bank Aktiengesellschaft started coverage on shares of Celsius in a report on Thursday, December 12th. They issued a “hold” rating and a $32.00 target price on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $47.56.

Insider Buying and Selling

In other Celsius news, major shareholder William H. Milmoe sold 65,000 shares of the firm’s stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $31.15, for a total transaction of $2,024,750.00. Following the sale, the insider now directly owns 261,245 shares of the company’s stock, valued at $8,137,781.75. This trade represents a 19.92 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.20% of the stock is owned by insiders.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.